In the market for a deal on a new car? If you can stretch to £300 per month, you’ll have a veritable treasure trove of finance deals to pick from. The sheer number of models that fall into this range ...

Lumakras’ approval for the mCRC indication was based on data from the phase III CodeBreaK 300 study, which evaluated Lumakras plus Vectibix versus the investigator's choice of therapy in KRAS ...

Approval is based on the pivotal phase 3 CodeBreaK 300 study, which demonstrated that Lumakras plus Vectibix is the first and only targeted treatment combination for chemorefractory KRAS G12C-mutated ...

In the past year, shares of Amgen have dropped 12.2% compared with the industry’s decline of 14.1%. Lumakras’ approval for the mCRC indication was based on data from the phase III CodeBreaK 300 study, ...

Approval is based on data from the Phase III CodeBreaK 300 trial, which demonstrated that treatment with Lumakras and Vectibix ... with metastatic disease survive beyond five years after diagnosis," ...

Approval of sotorasib with panitumumab was based on findings from the randomized, open-label, controlled CodeBreaK 300 trial showing ... but the study was not statistically powered for OS.

Love the timeless design, comfort & performance ... This car made me such a fan of the Chrysler 300 that I also now own a 2015. Even being 11 years old now, the 2008 still commands attention ...

This approval, based on results from the CodeBreaK 300 clinical trial, offers a new treatment option for patients who have progressed after prior chemotherapy regimens involving fluoropyrimidine, ...

Regulators based their decision on results of the phase III CodeBreaK 300 trial in which progression-free survival (PFS) was 5.6 months for those who received the combination versus 2 months for those ...